Literature DB >> 16949997

Chapter 2: The burden of HPV-related cancers.

D Maxwell Parkin1, Freddie Bray.   

Abstract

On the basis of current evidence regarding human papillomavirus (HPV) and cancer, this chapter provides estimates of the global burden of HPV-related cancers, and the proportion that are actually "caused" by infection with HPV types, and therefore potentially preventable. We also present trends in incidence and mortality of these cancers in the past, and consider their likely future evolution.

Entities:  

Mesh:

Year:  2006        PMID: 16949997     DOI: 10.1016/j.vaccine.2006.05.111

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  395 in total

1.  Novel betapapillomavirus associated with hand and foot papillomas in a cynomolgus macaque.

Authors:  C E Wood; S H Tannehill-Gregg; Z Chen; K van Doorslaer; D R Nelson; J M Cline; R D Burk
Journal:  Vet Pathol       Date:  2010-10-04       Impact factor: 2.221

2.  E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.

Authors:  Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  A national initiative for women and healthcare providers: CDC's Inside Knowledge: Get the Facts About Gynecologic Cancer campaign.

Authors:  Sun Hee Rim; Lindsey Polonec; Sherri L Stewart; Cynthia A Gelb
Journal:  J Womens Health (Larchmt)       Date:  2011-09-20       Impact factor: 2.681

Review 4.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

5.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

6.  Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.

Authors:  Subhashini Jagu; Kihyuck Kwak; Robert L Garcea; Richard B S Roden
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

7.  [Public health analysis -- human papillomavirus data and facts for Austria].

Authors:  Ursula Kunze; Gabriela Böhm
Journal:  Wien Klin Wochenschr       Date:  2010-12       Impact factor: 1.704

8.  Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Authors:  Naiyana Praditsitthikorn; Yot Teerawattananon; Sripen Tantivess; Supon Limwattananon; Arthorn Riewpaiboon; Saibua Chichareon; Nantakan Ieumwananonthachai; Viroj Tangcharoensathien
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

9.  Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets.

Authors:  Yingfei Ma; Ramana Madupu; Ulas Karaoz; Carlos W Nossa; Liying Yang; Shibu Yooseph; Patrick S Yachimski; Eoin L Brodie; Karen E Nelson; Zhiheng Pei
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 10.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.